Item 2.02 Results of Operations and Financial Condition. To the extent the information in Item 7.01 or Exhibit 99.1 relates to a completed fiscal period, such information is incorporated by reference into this Item 2.02.

Item 7.01 Regulation FD Disclosure. R1 RCM Inc. (the "Company") has prepared an investor presentation for use at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 10:50 a.m., Eastern Time. A copy of the investor presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein solely for purposes of this Item 7.01 disclosure. A live audio webcast and replay of the presentation will be available on the Investor Relations section of the Company's website at r1rcm.com. The archived webcast and the slides contained in Exhibit 99.1 will also be available for 30 days following the presentation on the Investor Relations section of the Company's website.

The investor presentation, the Company's website, and the other information in Items 2.02 and 7.01 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.




Item 9.01 Financial Statements and Exhibits.
(d)      Exhibit Number          Description
                  99.1             Presentation dated January 11, 2021
                   104           Cover Page Interactive Data File - the cover page iXBRL tags are
                                 embedded within the Inline XBRL document.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses